PepGen Inc. announced the appointment of Joseph Vittiglio, Esq., as Chief Business and Legal Officer.
Mr. Vittiglio brings over two decades of executive leadership experience in legal, compliance, and corporate governance in public biotechnology companies.
His appointment reflects PepGen's focus on advancing oligonucleotide therapies for severe neuromuscular and neurological diseases.
Experience and Expertise
Joseph Vittiglio brings a proven track record in guiding companies through complex transactions, regulatory milestones, financings, and strategic partnerships.
Significant Progress
PepGen continues advancing their PGN-EDODM1 program and prepares for readouts from the FREEDOM2-EDODM1 study in DM1 patients.
- The addition of Joseph Vittiglio strengthens PepGen's executive leadership team with extensive legal and business experience.
- His background in guiding companies through regulatory milestones and strategic partnerships aligns with PepGen's goals of transforming disease treatment.
The appointment of Joseph Vittiglio as Chief Business and Legal Officer marks a strategic move for PepGen Inc., enhancing their leadership team in the pursuit of innovative oligonucleotide therapies.